Paper39008152
Peptides for microbe-induced cancers: latest therapeutic strategies and their advanced technologies.
Lin Z and 2 others. Cancer Metastasis Rev, 2024. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Peptides for microbe-induced cancers: latest therapeutic strategies and their advanced technologies. Papers, record 39008152. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39008152
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Peptides for microbe-induced cancers: latest therapeutic strategies and their advanced technologies.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neoplasms | Major topic |
| Peptides | Major topic |
| Humans | |
| Animals | |
| Cancer Vaccines | |
| Antineoplastic Agents | |
| Helicobacter pylori |
Source PubMed
References117
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33364454 | Interplay between gut microbiota and antimicrobial peptides. | Anim Nutr | 2020 | https://conductscience.org/library/papers/33364454 | PubMed |
| 2 | 16272510 | Defining the normal bacterial flora of the oral cavity. | J Clin Microbiol | 2005 | https://conductscience.org/library/papers/16272510 | PubMed |
| 3 | 28316330 | The microbiota of the respiratory tract: gatekeeper to respiratory health. | Nat Rev Microbiol | 2017 | https://conductscience.org/library/papers/28316330 | PubMed |
| 4 | 31699101 | The microbiome of the upper respiratory tract in health and disease. | BMC Biol | 2019 | https://conductscience.org/library/papers/31699101 | PubMed |
| 5 | 24268438 | Functions of the skin microbiota in health and disease. | Semin Immunol | 2013 | https://conductscience.org/library/papers/24268438 | PubMed |
| 6 | 31862245 | Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. | Lancet Glob Health | 2020 | https://conductscience.org/library/papers/31862245 | PubMed |
| 7 | 34735653 | Adult T-Cell Leukemia: a Comprehensive Overview on Current and Promising Treatment Modalities. | Curr Oncol Rep | 2021 | https://conductscience.org/library/papers/34735653 | PubMed |
| 8 | 20495574 | Helicobacter pylori: gastric cancer and beyond. | Nat Rev Cancer | 2010 | https://conductscience.org/library/papers/20495574 | PubMed |
| 9 | 33536635 | Trends in peptide drug discovery. | Nat Rev Drug Discov | 2021 | https://conductscience.org/library/papers/33536635 | PubMed |
| 10 | 32505833 | HBV induced hepatocellular carcinoma and related potential immunotherapy. | Pharmacol Res | 2020 | https://conductscience.org/library/papers/32505833 | PubMed |
| 11 | 24821878 | Human papillomavirus genotyping and p16 expression as prognostic factors for patients with American Joint Committee on Cancer stages I to III carcinoma of the anal canal. | J Clin Oncol | 2014 | https://conductscience.org/library/papers/24821878 | PubMed |
| 12 | 36951547 | A Review of Gut Microbiota-Derived Metabolites in Tumor Progression and Cancer Therapy. | Adv Sci (Weinh) | 2023 | https://conductscience.org/library/papers/36951547 | PubMed |
| 13 | 35533800 | Microbiota and gastric cancer. | Semin Cancer Biol | 2022 | https://conductscience.org/library/papers/35533800 | PubMed |
| 14 | 33857756 | Targeted nanomedicine modalities for prostate cancer treatment. | Drug Resist Updat | 2021 | https://conductscience.org/library/papers/33857756 | PubMed |
| 15 | 24421902 | Microbial dysbiosis is associated with human breast cancer. | PLoS One | 2014 | https://conductscience.org/library/papers/24421902 | PubMed |
| 16 | 28397767 | Helicobacter pylori Strains and Gastric MALT Lymphoma. | Toxins (Basel) | 2017 | https://conductscience.org/library/papers/28397767 | PubMed |
| 17 | 30013618 | The controversial role of Enterococcus faecalis in colorectal cancer. | Ther Adv Gastroenterol | 2018 | https://conductscience.org/library/papers/30013618 | PubMed |
| 18 | 35317845 | Chlamydia pneumoniae infections and development of lung cancer: systematic review. | Infect Agent Cancer | 2022 | https://conductscience.org/library/papers/35317845 | PubMed |
| 19 | 33122098 | HPV post-infection microenvironment and cervical cancer. | Cancer Lett | 2021 | https://conductscience.org/library/papers/33122098 | PubMed |
| 20 | 16597322 | Molecular biology of human papillomavirus infection and cervical cancer. | Clin Sci (Lond) | 2006 | https://conductscience.org/library/papers/16597322 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41491293 | NKG2D genetic variants and cancer susceptibility: Integrating case-control evidence with meta-analysis. | Immunogenetics | 2026 | https://conductscience.org/library/papers/41491293 | PubMed |
| 41254656 | Nanodynamic therapy for cancer: mechanistic innovations, targeting strategies and multimodal treatments. | J Transl Med | 2025 | https://conductscience.org/library/papers/41254656 | PubMed |
| 41080733 | Cholesterol modified defense peptide as an EMP2-siRNA delivery system for synergistic immunogene therapy against breast cancer. | Mater Today Bio | 2025 | https://conductscience.org/library/papers/41080733 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39008152
GET https://conductscience.org/api/papers/v1/39008152/references?page=2